Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Lactobacillus Casei

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    9 result(s) found for: Lactobacillus Casei. Displaying page 1 of 1.
    EudraCT Number: 2007-007179-18 Sponsor Protocol Number: LACTO 07 Start Date*: 2008-02-15
    Sponsor Name:SOFAR SPA
    Full Title: Evaluation of the ability of the probiotic Lactobacillus casei DG (Enterolactis) to remain into the bladder of patients with spinal cord injury and subject to intermitted catheterization. An open-l...
    Medical condition: patients with spinal cord injury and subject to intermitted vesical catheterization and recurrence of urinary tract infections
    Disease: Version SOC Term Classification Code Term Level
    9.1 10054088 Urinary tract infection bacterial LLT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2020-000228-20 Sponsor Protocol Number: 16012020001 Start Date*: 2020-08-28
    Sponsor Name:Medical University of Graz
    Full Title: Probiotic dietary Intervention in Polycystic Ovary Syndrome – A Randomized Controlled Trial
    Medical condition: Polycystic Ovary Syndrome (PCOS) is a hormonal and metabolic disorder affecting up to 20 percent of women worldwide, depending on diagnostic criteria. A very common definition of PCOS based on the ...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-003944-38 Sponsor Protocol Number: 15-PP-13 Start Date*: 2016-04-19
    Sponsor Name:CHU NICE
    Full Title: Treatment of the oral aphtose récidivante and idiopathique of the adult by probiotics Double-blind randomized interventional study versus placebo
    Medical condition: aphtous stoma
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2011-005833-38 Sponsor Protocol Number: LCR35_ESBL-01 Start Date*: 2012-07-03
    Sponsor Name:Medical University of Vienna
    Full Title: Removal of intestinal colonization with multi resistant bacteria by ingestion of Lactobacillus casei rhamnosus LCR 35
    Medical condition: Intestinal colonisation with multiresistant bacteria
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10069719 Bacterial colonisation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-006322-26 Sponsor Protocol Number: 1249 Start Date*: 2006-09-19
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: MESALAZINE AND/OR LACTOBACILLUS CASEI IN MAINTAINING REMISSION OF SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON: A PROSPECTIVE, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED STUDY
    Medical condition: DIVERTICULAR DISEASE
    Disease: Version SOC Term Classification Code Term Level
    14.1 10017947 - Gastrointestinal disorders 10013535 Diverticular disorders HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-019104-23 Sponsor Protocol Number: Gastro CHU 09-1 Start Date*: 2010-07-09
    Sponsor Name:THT Research sprl
    Full Title: Etude prospective de l'efficacité d'un mélange probiotique dans le syndrome du colon irritable.
    Medical condition: Syndrome du colon irritable (irritable bowel syndrome)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10023003 Irritable bowel syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002418-39 Sponsor Protocol Number: DG 01/05 Start Date*: 2005-10-20
    Sponsor Name:SOFAR SPA
    Full Title: Valutation of the efficacy of Lactobacillus casei subspeciae casei DG in prevention of Crohn s disease relapse after induction of clinical remission by antibiotics a multicentric, randomised, doub...
    Medical condition: prevention of Crohn s disease relapse
    Disease: Version SOC Term Classification Code Term Level
    6.1 10011401 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-003089-34 Sponsor Protocol Number: HND-IM-011 Start Date*: 2011-09-06
    Sponsor Name:Chr. Hansen A/S
    Full Title: The effect for Lactobacillus paracasei subsp. paracasei, L. casei 431® on immune response to influenza vaccination in healthy adult volunteers - a multi-center, randomized, placebo-controlled, par...
    Medical condition: effect of probiotics on the immune response to seasonal influenza vaccination in healthy adults
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10016794 Flu vaccination LLT
    14.1 10042613 - Surgical and medical procedures 10036897 Prophylactic vaccination LLT
    14.1 10042613 - Surgical and medical procedures 10046859 Vaccination LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-017901-12 Sponsor Protocol Number: LYO_2009-09 Start Date*: 2010-02-26
    Sponsor Name:LYOCENTRE
    Full Title: Etude de l’efficacité et de la tolérance du traitement par la culture totale lyophilisée de lactobacillus casei variété rhamnosus (Lcr35 Lc) administré par voie vaginale dans la prévention de réci...
    Medical condition: vaginose bactérienne récidivante
    Disease: Version SOC Term Classification Code Term Level
    12.1 10004055 Bacterial vaginosis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 22:09:27 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA